ABSTRACT Nucleolar organiser regions represent nucleolar activity in both normal and malignant cells. More numerous nucleolar organiser regions have been found in cells from many forms of malignancy than in normal cells. An argyrophilic method of staining these regions (the AgNOR technique) has been applied to specimens ofpleura obtained by biopsy or at necropsy in an attempt to differentiate between normal, "reactive," and malignant pleural disease. The number of nucleolar organiser regions in samples taken from 10 patients with normal pleura (mean 1 04 (95 % confidence interval 0-96-1 12)) was less than the number seen in samples from 10 patients with "reactive" (inflammatory) pleural disease (1-75 (1 34-2 16); p < 0-001). This is the first demonstration of increased numbers ofnucleolar organiser regions in an inflammatory condition. In specimens from 25 patients with mesothelioma the corresponding numbers of nucleolar organiser regions were: tubulopapillary (n = 10) 5.43 (4 42-6A44); undifferentiated (n = 5) 5-00 (3-29-6.71); sarcomatous (n = 5) 7 52 (3-96-11 08); and mixed histological types (n = 5) 4-94 (3 2-6-68). All these values differ significantly from those for both normal and "reactive" tissue (p < 0-001). It is concluded that the AgNOR technique separates "reactive" pleural disease from mesothelioma with a high degree of confidence and is an important advance in the diagnosis of malignant mesothelioma. Malignant mesothelioma is an uncommon tumour with variable histological appearances.9 The two major areas of difficulty in the pathological diagnosis of this tumour are in its differentiation from adenocar-
Nucleolar organiser regions represent areas of ribosomal DNA on certain chromosomes from which ribosomal RNA is formed' and their numbers per nucleus are thought to reflect nucleolar activity.2 Studies of various forms of malignancy3 (prostatic carcinoma,2 melanocarcinoma,4 small cell bronchogenic carcinoma,5 and carcinoma of the breast6) have confirmed that enumeration of nucleolar organiser regions as identified by an argyrophilic method (the AgNOR technique) permits clear differentiation of malignant from benign tissue. This technique stains proteins associated with nucleolar organiser regions.7
In non-Hodgkin's lymphoma' the numbers of nucleolar organiser regions are related to the degree of malignancy of the tumours.
Malignant mesothelioma is an uncommon tumour with variable histological appearances. 9 The two major areas of difficulty in the pathological diagnosis of this tumour are in its differentiation from adenocar-cinoma and, in pleural biopsy specimens, in defining whether the mesothelial cells are "reactive" or malignant. In an attempt to throw light on the latter problem we have applied the AgNOR technique to normal pleura and to pleura obtained from patients with "reactive" and malignant pleural disease to determine whether this simple staining method can help to separate benign from malignant disease of the pleura.
Methods
Blocks of pleural tissue obtained at thoracotomy or necropsy were studied. Specimens were obtained from 10 subjects with normal pleura, from 10 subjects with pleura having "reactive" histological changes, and from 25 patients with mesothelioma. In ofthe patient. In the case ofthe postmortem specimens all the patients had had pneumonia with pleurisy. In three cases the pneumonia was distal to an obstructing tumour, but there was no histological evidence of tumour in the area from which the biopsy specimen for this study was taken. Normal pleura was obtained from resected lobes or lungs for localised carcinomas with no peripheral extension of tumour. Mesothelioma tissue was obtained by open lung biopsy in each case; the tumour was classified according to the nomenclature used by Whitwell and Rawcliffe.'°O f the 25 specimens, 10 were tubulopapillary, five undifferentiated polygonal cell, five sarcomatous, and five mixed type tumours. The nature of the tumours was confirmed by positive alcian blue-hyaluronidase staining and lack of immunohistochemical reaction for carcinoembryonic antigen.
The method for staining nucleolar organiser regions is fully described elsewhere.8 Briefly, sections were dewaxed, taken to water, and washed in deionised, distilled water. The reaction mixture consisted of gelatin in 1 g/dl formic acid to make a 2 g/dl solution, which was then mixed with 50 g/dl silver nitrate in a proportion of 1:2. After 30 minutes' incubation at room temperature in the dark the specimens were washed, taken to xylene, and mounted in synthetic medium. For each sample the number of silver stained nucleolar organiser regions (AgNORs) in 100 cells were counted with the aid of a graticule, with careful focusing on each cell to enable clear identification of each AgNOR dot. It is impossible to enumerate AgNOR dots without knowledge of the histological type; interobserver variation in our hands is of the order of 10%. Cells and fields were selected at random. In the mixed type of tumour, acinar and spindle cells were counted in proportion to their presence in the biopsy specimen. Inflammatory and stromal cells (such as endothelial cells and fibroblasts) were excluded.
For statistical analysis we used Student's t test for unpaired data and calculation of 95% confidence intervals (CI).
Results
The mean number of AgNOR dots per nucleus was 1-04 (95% CI 0.96-1-12) for normal mesothelial cells in a consistent manner. Our findings confirm that the cells from all four types of mesothelioma have more AgNORs than cells from either normal or "reactive" pleura, the largest number being in the sarcomatous form. We must emphasise that the sections used in this study were cut at 3 gm thickness, and the quoted numbers of AgNOR dots thus are not absolute numbers of nucleolar organiser regions per nucleus, which can be obtained only from cell imprint preparations. 8 The configuration and distribution of the AgNORs (found only on chromosomes 13, 14, 15, 21, and 22 in normal human cells'4) have yet to be investigated fully in malignant cells, although "ectopic" AgNORs have been reported in metaphase spreads of testicular cancer and myeloid leukaemia cells. ' 16 The finding that "reactive" cells can be separated from normal cells by this technique shows for the first time that this method may be extended to the investigation ofinflammatory diseases. Further investigation here should look at possible differences between the nucleolar organiser regions of inflammatory lesions and those of low grade malignancy.
The prognosis of mesothelioma is very poor, most patients dying within two years of presentation. It is important when a patient with a pleural effusion has been exposed to asbestos to obtain a firm diagnosis. The benign pleural effusion associated with asbestos exposure carries a far better prognosis, '7 although there is some suggestion that the condition might be premalignant. Assessment of mesothelial cells from such patients with the AgNOR technique would be of interest, diagnostically in the first instance, and over a long period with serial measurements that might help to detect the development of malignant change. 
